1-苄基-1H-吲哚-5-甲胺 | 26807-73-8

• 物质功能分类: 医药中间体 - 杂环化合物 - 吲哚类化合物
• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吲哚及其衍生物
• 中文名称: 1-苄基-1H-吲哚-5-甲胺
• 英文名称: 1-benzyl-1H-indol-5-amine
• 英文别名: 1-benzyl-1H-indole-5-amine；5-amino-1-benzylindole；5-amino-1-benzyl-(1H)-indole；1-Benzyl-1H-indol-5-ylamine；1-benzylindol-5-amine
• CAS: 26807-73-8
• 化学式: C₁₅H₁₄N₂
• mdl: MFCD03070173
• 分子量: 222.29
• InChiKey: UYDNPZLYDODKKA-UHFFFAOYSA-N

物化性质

• 沸点：
  447.0±28.0 °C(Predicted)
• 密度：
  1.13±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.9
• 重原子数：
  17
• 可旋转键数：
  2
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.07
• 拓扑面积：
  31
• 氢给体数：
  1
• 氢受体数：
  1

安全信息

• 安全说明：
  S24/25
• 包装等级：
  III
• 危险类别：
  8
• 危险性防范说明：
  P280,P305+P351+P338
• 危险品运输编号：
  3259
• 危险性描述：
  H302,H318
• 储存条件：
  应存储在室温、避光且充满惰性气体的环境中。

SDS

Name:	1-Benzyl-1h-indol-5-ylamine 97% Material Safety Data Sheet
Synonym:
CAS:	26807-73-8

Section 1 - Chemical Product MSDS Name:1-Benzyl-1h-indol-5-ylamine 97% Material Safety Data Sheet
Synonym:

---

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS

CAS#	Chemical Name	content	EINECS#
26807-73-8	1-Benzyl-1H-indol-5-ylamine	97%	unlisted

Hazard Symbols: None Listed.
Risk Phrases: None Listed.

---

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
Not available.
Potential Health Effects
Eye:
May cause eye irritation.
Skin:
May cause skin irritation. May be harmful if absorbed through the skin.
Ingestion:
May cause irritation of the digestive tract. May be harmful if swallowed.
Inhalation:
May cause respiratory tract irritation. May be harmful if inhaled.
Chronic:
Not available.

---

Section 4 - FIRST AID MEASURES
Eyes: Flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes.
Ingestion:
Get medical aid. Wash mouth out with water.
Inhalation:
Remove from exposure and move to fresh air immediately.
Notes to Physician:
Treat symptomatically and supportively.

---

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear.
Extinguishing Media:
Use water spray, dry chemical, carbon dioxide, or chemical foam.

---

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Absorb spill with inert material (e.g. vermiculite, sand or earth), then place in suitable container. Vacuum or sweep up material and place into a suitable disposal container.

---

Section 7 - HANDLING and STORAGE
Handling:
Avoid breathing dust, vapor, mist, or gas. Avoid contact with skin and eyes.
Storage:
Store in a cool, dry place. Store in a tightly closed container.

---

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 26807-73-8: Personal Protective Equipment Eyes: Not available.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.

---

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Solid or liquid
Color: Not available.
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: Not available.
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C15H14N2
Molecular Weight: 222.29

---

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Not available.
Conditions to Avoid:
Incompatible materials.
Incompatibilities with Other Materials:
Strong oxidizing agents.
Hazardous Decomposition Products:
Carbon monoxide, carbon dioxide.
Hazardous Polymerization: Has not been reported

---

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 26807-73-8 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
1-Benzyl-1H-indol-5-ylamine - Not listed by ACGIH, IARC, or NTP.

---

Section 12 - ECOLOGICAL INFORMATION

---

Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

---

Section 14 - TRANSPORT INFORMATION

IATA
No information available.
IMO
No information available.
RID/ADR
No information available.

---

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: Not available.
Risk Phrases:
Safety Phrases:
S 24/25 Avoid contact with skin and eyes.
WGK (Water Danger/Protection)
CAS# 26807-73-8: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 26807-73-8 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 26807-73-8 is not listed on the TSCA inventory.
It is for research and development use only.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  1-苄基-1H-吲哚-5-甲胺 在 吡啶盐酸盐 、 铁粉 、 溶剂黄146 作用下， 以 甲醇 、 异丙醇 为溶剂， 反应 10.0h， 生成 6-Amino-4-(1-benzyl-1H-indol-5-ylamino)-7-ethoxy-quinoline-3-carbonitrile
  参考文献：
  名称：

  优化6,7-二取代的-4-（芳基氨基）喹啉-3-甲腈作为人类表皮生长因子受体2激酶活性的口服活性，不可逆抑制剂的作用。

  摘要：

  一系列新的6,7-二取代的4-（芳基氨基）喹啉-3-甲腈衍生物可作为人类表皮生长因子受体2（HER-2）和表皮生长因子受体（EGFR）激酶的不可逆抑制剂发挥作用。准备好了。与我们的EGFR激酶抑制剂86（EKB-569）相比，这些化合物表现出增强的抑制HER-2激酶和HER-2阳性细胞生长的活性。使用三种合成途径来制备这些化合物。它们的制备主要是通过6-氨基-4-（芳基氨基）喹啉-3-腈与不饱和酰氯的酰化作用或通过4-氯-6-（巴豆酰胺基）喹啉-3-腈与单环或双环苯胺的胺化而制备的。开发了第三条路线来制备关键中间体，即6-乙酰氨基-4-氯喹啉-3-腈，该中间体涉及更安全的环化步骤。我们显示，在4-（芳基氨基）环的对位上附加一个大的亲脂基团会导致抑制HER-2激酶的效力提高。我们还显示了在迈克尔受体末端的碱性二烷基氨基对于活性的重要性，这归因于迈克尔加成的分子内催化作用。这与改善的水溶性一起

  DOI：

  10.1021/jm040159c
• 作为产物：
  描述：

  5-硝基吲哚 在 palladium on activated charcoal 氢气 、 sodium hydride 作用下， 以 乙醇 、 N,N-二甲基甲酰胺 为溶剂， 20.0 ℃ 、241.32 kPa 条件下， 生成 1-苄基-1H-吲哚-5-甲胺
  参考文献：
  名称：

  新型吲哚硫辛酸衍生物的合成及其对脂质过氧化的抗氧化作用

  摘要：

  该研究的目的是检查基于吲哚和硫辛酸部分的缀合物的抗氧化特性。进行了新型吲哚α-硫辛酸衍生物的设计和合成。使用大鼠肝微粒体、NADPH 依赖性脂质过氧化抑制研究了目标化合物的抗氧化特性。与α-硫辛酸相比，一些目标化合物，特别是那些在吲哚环的第5位含有酰胺接头的化合物，被证明在抑制脂质过氧化方面非常有效。

  DOI：

  10.1002/ardp.200400932

文献信息

• [EN] PROTEIN KINASE INHIBITORS AND USE THEREOF<br/>[FR] INHIBITEURS DE PROTÉINE KINASE ET LEUR UTILISATION
  申请人：MERCK SERONO SA

  公开号：WO2009108670A1

  公开（公告）日：2009-09-03

  Disclosed are benzonaphthyridinyl derivative compounds and analogs thereof, pharmaceutical compositions comprising such compounds and processes for preparing the same. The compounds are useful in the treatment of diseases amenable to kinase signal transduction inhibition, regulation or modulation.

  揭示了苯并萘啶衍生物化合物及其类似物，包括含有这些化合物的药物组合物以及制备这些化合物的方法。这些化合物在治疗对激酶信号传导抑制、调节或调控敏感的疾病中很有用。
• Highly selective reduction of nitroarenes by iron(0) nanoparticles in water
  作者：Raju Dey、Nirmalya Mukherjee、Sabir Ahammed、Brindaban C. Ranu

  DOI：10.1039/c2cc30999h

  日期：——

  Highly selective reduction of nitroarenes has been achieved using iron metal nanoparticles in water at room temperature. A wide spectrum of reducible functionalities remained inert under the reaction conditions. During the reaction a change in shape of Fe nanoparticles was observed.

  在室温下的水相环境中，利用铁金属纳米颗粒实现了硝基芳烃的高度选择性还原。在反应条件下，广泛的还原性官能团保持惰性。反应过程中观察到了铁纳米颗粒形状的变化。
• CYANOQUINOLINE DERIVATIVES
  申请人：Zhang Hesheng

  公开号：US20130225579A1

  公开（公告）日：2013-08-29

  Disclosed is a compound of formula I, a stereoisomer thereof, a cis-trans-isomer thereof, a tautomer thereof, or a mixture thereof, or a pharmaceutically acceptable salt thereof, a solvate thereof or a prodrug thereof, wherein R 1 , R 2 , R 3 and R 4 are each as defined in the present application.

  公开了一种公式I的化合物，其立体异构体，其顺反异构体，其互变异构体，或它们的混合物，或其药物可接受的盐，其溶剂化物或其前药，其中R1，R2，R3和R4各自如在本申请中定义。
• INDOLYL OR INDOLINYL HYDROXAMATE COMPOUNDS
  申请人：Chen Ching-Shih

  公开号：US20110245315A1

  公开（公告）日：2011-10-06

  Indolyl or indolinyl compounds of formula (I): wherein bond, n, R 1 , R 2 , R 3 , R 4 , R 5 , and R 6 , are defined herein. Also disclosed is a method for treating cancer with these compounds.

  式(I)的吲哚基或吲哚啉基化合物： 其中 键，n，R1，R2，R3，R4，R5和R6在此定义。还公开了一种使用这些化合物治疗癌症的方法。
• One-Pot Protocol To Synthesize 2-Aminophenols from Anilines via Palladium-Catalyzed C–H Acetoxylation
  作者：Junhao Zhao、Yifeng Huang、Guojian Ma、Ling Lin、Pengju Feng

  DOI：10.1021/acs.organomet.9b00113

  日期：2019.5.13

  one-pot protocol to synthesize 2-aminophenol derivatives via a palladium-catalyzed C–H acetoxylation strategy with 5-nitropyrimidine as a directing group (DG), which can be easily preinstalled and readily removed under mild condition after the coupling. In addition, the transformation is operationally simple, has high functional group tolerance, and is amenable to gram-scale. Moreover, several examples

  本文介绍了一种简便的一锅操作方案，该方法通过钯催化的CH5-H乙酰氧基化策略，以5-硝基嘧啶为导向基团（DG）来合成2-氨基苯酚衍生物，可以很容易地进行预安装，并在温和的条件下容易地将其除去。耦合。另外，该转化操作简单，具有高官能团耐受性，并且适合克规模。此外，几个例子表明，可以将5-硝基嘧啶的引入/去除和CH的羟基氧化序列整合到一个罐中。